Menu
Back to Journals » Cancer Management and Research » Volume 13
Original Research
Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,974 | Dovepress* | 7,101+ | 405 | 7,506 | |
| PubMed Central* | 873 | 307 | 1,180 | ||
| Totals | 7,974 | 712 | 8,686 | ||
| *Since 9 August 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 12 | 1 | 0 | 0 | 4 | 7 |
View citations on PubMed Central and Google Scholar